U.S. advisers reject higher dose of N...

U.S. advisers reject higher dose of Novartis lung drug

There are 2 comments on the WOZZ-FM Appleton story from Mar 8, 2011, titled U.S. advisers reject higher dose of Novartis lung drug. In it, WOZZ-FM Appleton reports that:

Novartis AG failed to win support from a U.S. advisory panel for the highest proposed dose of a new lung drug, a setback that could delay development of a potential blockbuster medicine.

Join the discussion below, or Read more at WOZZ-FM Appleton.

just candid

AOL

#1 Mar 9, 2011
COPD is something you never recover from.
All you can do is delay its progress. It's 3rd or 4th killer in the US. There should be some common sense used and anything that may help should be seriously considered. What works for one person may not help another, so there has to be some leway in type of drug/s tried and used.
COPD clinical trials

Little Rock, AR

#2 Mar 25, 2011

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Novartis Discussions

Title Updated Last By Comments
News Analyst: A Complete List of All Major Biosimila... (Apr '15) Apr '15 DawnMEcker 1
News Teva gets Fda Ok for generic of herpes drug Famvir (Oct '07) Jun '14 Liza_R 5
News Women With Breast Cancer No Longer Have to Sett... (Aug '06) Nov '13 kit 64
News New warnings on ADHD drugs (Aug '06) Sep '13 Joey 6
News For GSK, other drug giants, pipelines rebound -... (Feb '13) Feb '13 GSK Maims Kills 2
News Mylan Inc. Tries to Get Its Hands on Ranbaxy La... (Dec '12) Dec '12 Jrseyan 1
News FDA Is Rejecting More New Drugs - (Aug '07) Dec '11 Pamela McCreary 3
More from around the web